Atlas Trials

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Clinical trial NCT03950154 · UNKNOWN

Trial details

NCT number
NCT03950154
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2019-06-01
Primary completion
2023-08-01
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.